AMGEN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Amgen (AMGN) Tops Q3 EPS by 25c, Offers Guidance
November 3, 2022 4:03 PM EDTAmgen (NASDAQ: AMGN) reported Q3 EPS of $4.70, $0.25 better than the analyst estimate of $4.45. Revenue for the quarter came in at $6.7 billion versus the consensus estimate of $6.58 billion.
GUIDANCE:
Amgen sees FY2022 EPS of $17.25-$17.85, versus the consensus of $17.50. Amgen sees... More
